• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体外抗肿瘤药效学研究的设计与分析

Design and analysis of in vitro antitumor pharmacodynamic studies.

作者信息

Kalns J E, Millenbaugh N J, Wientjes M G, Au J L

机构信息

Division of Pharmaceutics and Pharmaceutical Chemistry, College of Pharmacy, Ohio State University, Columbus 43210, USA.

出版信息

Cancer Res. 1995 Nov 15;55(22):5315-22.

PMID:7585594
Abstract

The relationship between drug concentration (C), exposure time (t), and the resulting effect (h) for a chemotherapeutic agent is expressed as Cn x t = h. The value of n, derived from curve fitting of the C versus t plot, indicates the relative importance of concentration and exposure time. The selection of concentrations and exposure times in a pharmacodynamic experiment may affect the precision and accuracy of parameter estimation. The use of optimal designs is even more critical when the numbers of experimental conditions are limited by tumor availability (e.g., small size of surgical specimens from patients). The present study used computer-simulated data to define the most efficient in vitro pharmacodynamic experimental designs and the optimal method of pharmacodynamic data analysis. All studies used Monte Carlo simulations to compare designs with varying numbers of drug concentrations, exposure times, and replications. For each selected design, 50-100 error-containing data sets were created by addition of experience-based random errors to expected concentration-response profiles. To compare methods of data analysis, the same 1250 simulated data sets were analyzed by two methods (i.e., surface response method and traditional method). The results showed that simultaneous fitting of drug effect at all concentrations and all exposure times by the surface response method yielded n estimates that had greater precision and accuracy than a traditional method that required sequential determination of the effective inhibitory concentration (e.g., IC50) and then the n value using the IC50 at different exposure times. Subsequent studies were analyzed using the surface response method. To evaluate the effect of selection of concentrations and exposure times on the precision of n estimation, between 1100 and 2200 simulated data sets, with 400 observations per data set, were generated using different exposure times and drug concentrations. Because the number of observations was limited to 400, the number of replications at each condition varied depending on the total number of selected conditions.(ABSTRACT TRUNCATED AT 400 WORDS)

摘要

化疗药物的药物浓度(C)、暴露时间(t)与所产生的效应(h)之间的关系表示为Cⁿ×t = h。通过C对t的曲线拟合得出的n值表明了浓度和暴露时间的相对重要性。药效学实验中浓度和暴露时间的选择可能会影响参数估计的精度和准确性。当实验条件的数量受肿瘤可获得性限制时(例如,患者手术标本尺寸较小),使用最优设计更为关键。本研究使用计算机模拟数据来确定最有效的体外药效学实验设计以及药效学数据分析的最优方法。所有研究都使用蒙特卡罗模拟来比较具有不同药物浓度、暴露时间和重复次数的设计。对于每个选定的设计,通过向预期的浓度 - 反应曲线添加基于经验的随机误差来创建50 - 100个包含误差的数据集。为了比较数据分析方法,用两种方法(即表面响应法和传统方法)分析相同的1250个模拟数据集。结果表明,与传统方法相比,表面响应法对所有浓度和所有暴露时间的药物效应进行同时拟合得出的n估计值具有更高的精度和准确性,传统方法需要顺序确定有效抑制浓度(例如,IC50),然后使用不同暴露时间下的IC50来确定n值。后续研究使用表面响应法进行分析。为了评估浓度和暴露时间的选择对n估计精度的影响,使用不同的暴露时间和药物浓度生成了1100至2200个模拟数据集,每个数据集有400个观测值。由于观测值数量限制为400,每个条件下的重复次数根据所选条件的总数而有所不同。(摘要截断于400字)

相似文献

1
Design and analysis of in vitro antitumor pharmacodynamic studies.体外抗肿瘤药效学研究的设计与分析
Cancer Res. 1995 Nov 15;55(22):5315-22.
2
In vitro pharmacodynamic assay for cancer drug development: application to crisnatol, a new DNA intercalator.
Cancer Res. 1989 Dec 1;49(23):6615-20.
3
A pharmacodynamic analysis method to determine the relative importance of drug concentration and treatment time on effect.一种用于确定药物浓度和治疗时间对疗效相对重要性的药效学分析方法。
Cancer Chemother Pharmacol. 2000;45(4):265-72. doi: 10.1007/s002800050039.
4
In vitro cell growth pharmacodynamic studies: a new nonparametric approach to determining the relative importance of drug concentration and treatment time.
Cancer Chemother Pharmacol. 2003 Dec;52(6):507-13. doi: 10.1007/s00280-003-0688-7. Epub 2003 Aug 16.
5
Modeling of the time-dependency of in vitro drug cytotoxicity and resistance.体外药物细胞毒性和耐药性的时间依赖性建模。
Cancer Res. 1998 Dec 15;58(24):5749-61.
6
Simultaneous versus sequential pharmacokinetic-pharmacodynamic population analysis using an iterative two-stage Bayesian technique.使用迭代两阶段贝叶斯技术进行同步与序贯药代动力学-药效学群体分析。
Biopharm Drug Dispos. 2007 Nov;28(8):455-73. doi: 10.1002/bdd.575.
7
[Meta-analysis of the Italian studies on short-term effects of air pollution].[意大利关于空气污染短期影响研究的荟萃分析]
Epidemiol Prev. 2001 Mar-Apr;25(2 Suppl):1-71.
8
Ethyl methanesulfonate toxicity in Viracept--a comprehensive human risk assessment based on threshold data for genotoxicity.奈韦拉平中甲烷磺酸乙酯的毒性——基于遗传毒性阈值数据的全面人体风险评估
Toxicol Lett. 2009 Nov 12;190(3):317-29. doi: 10.1016/j.toxlet.2009.04.003. Epub 2009 Apr 10.
9
Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.长期暴露于交通相关空气污染对荷兰呼吸道和心血管疾病死亡率的影响:荷兰长期队列空气污染研究(NLCS-AIR研究)
Res Rep Health Eff Inst. 2009 Mar(139):5-71; discussion 73-89.
10
A mechanistic, predictive model of dose-response curves for cell cycle phase-specific and -nonspecific drugs.针对细胞周期阶段特异性和非特异性药物的剂量反应曲线的一种机制性预测模型。
Cancer Res. 2000 Mar 1;60(5):1417-25.

引用本文的文献

1
A new mathematical pharmacodynamic model of clonogenic cancer cell death by doxorubicin.多柔比星诱导肿瘤细胞克隆性死亡的新的数学药效动力学模型。
J Pharmacokinet Pharmacodyn. 2013 Aug;40(4):513-25. doi: 10.1007/s10928-013-9326-0. Epub 2013 Jul 18.
2
Compound ranking based on a new mathematical measure of effectiveness using time course data from cell-based assays.基于一种使用来自细胞检测的时间进程数据的新有效性数学度量的化合物排名。
Comb Chem High Throughput Screen. 2013 Mar;16(3):168-79. doi: 10.2174/1386207311316030002.
3
Pharmacodynamic modelling of biomarker data in oncology.
肿瘤学中生物标志物数据的药效学建模
ISRN Pharmacol. 2012;2012:590626. doi: 10.5402/2012/590626. Epub 2012 Feb 16.
4
Accuracy and precision of pharmacodynamic exponent.药效学指数的准确性和精密度。
Pharm Res. 1999 Jan;16(1):170-3. doi: 10.1023/a:1011903719732.